Amplifyer Bio, Inc. is an exciting new startup developing technology of transformative potential for the liquid biopsy field and the product of a collaboration between the labs of Dr. Sangeeta Bhatia, Dr. Chris Love and Dr. Viktor Adalsteinsson at MIT and the Broad Institute.
The work has been published in Science and has been presented at leading conferences both in the US and internationally. The company is focused on the development of novel priming agents that in combination with current liquid biopsy diagnostics will improve test performance. Amplifyer’s first program will be focused on increasing cfDNA in blood for cancer diagnostics. This will provide both physicians and patients higher quantity and quality
of genomic information related to their cancer, with the aim of improving clinical outcomes.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 238 Main St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://amplifyer.bio
- HQ
- Cambridge, Massachusetts
Amplifyer Bio Questions
Amplifyer Bio's website is http://amplifyer.bio
Amplifyer Bio's LinkedIn profile is https://www.linkedin.com/company/amplifyer-bio
Amplifyer Bio has
9 employees.
View email and phone details for 9
employees at Amplifyer Bio.
Amplifyer Bio's industry is
Biotechnology Research
Amplifyer Bio's top competitors are
Matrisome Bio,
Nova,
Sunbird Bio,
Satellite Bio,
Amplifye,
Ropirio Therapeutics, Inc.,
Cirrus Therapeutics,
Port Therapeutics,
Bioivt,
Thymmune Therapeutics.
Amplifyer Bio's categories are Biotechnology Research
Amplifyer Bio's founding year is 2023
